El Pollo Loco Holdings, Inc. Announces Third Quarter 2016 Financial Results
Nov 03, 2016 20:07 pm UTC| Business
COSTA MESA, Calif., Nov. 03, 2016 -- El Pollo Loco Holdings, Inc. (Nasdaq:LOCO) today announced financial results for the 13-week period ended September 28, 2016. Highlights for the third quarter ended September 28,...
El Pollo Loco Holdings, Inc. Announces Third Quarter 2016 Financial Results
Nov 03, 2016 20:07 pm UTC| Business
COSTA MESA, Calif., Nov. 03, 2016 -- El Pollo Loco Holdings, Inc. (Nasdaq:LOCO) today announced financial results for the 13-week period ended September 28, 2016. Highlights for the third quarter ended September 28,...
El Pollo Loco Holdings, Inc. Announces Third Quarter 2016 Financial Results
Nov 03, 2016 20:07 pm UTC| Business
COSTA MESA, Calif., Nov. 03, 2016 -- El Pollo Loco Holdings, Inc. (Nasdaq:LOCO) today announced financial results for the 13-week period ended September 28, 2016. Highlights for the third quarter ended September 28,...
Autobytel Reports Third Quarter 2016 Results
Nov 03, 2016 20:07 pm UTC| Business
IRVINE, Calif., Nov. 03, 2016 -- Autobytel Inc. (NASDAQ:ABTL), a pioneer and leading provider of digital automotive services connecting in-market car buyers with dealers and OEMs, reported financial results for the...
Autobytel Reports Third Quarter 2016 Results
Nov 03, 2016 20:07 pm UTC| Business
IRVINE, Calif., Nov. 03, 2016 -- Autobytel Inc. (NASDAQ:ABTL), a pioneer and leading provider of digital automotive services connecting in-market car buyers with dealers and OEMs, reported financial results for the...
CytomX Therapeutics Announces Third Quarter 2016 Financial Results and Provides Pipeline Update
Nov 03, 2016 20:07 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2016 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today reported third...
CytomX Therapeutics Announces Third Quarter 2016 Financial Results and Provides Pipeline Update
Nov 03, 2016 20:06 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2016 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today reported third...